Revenue
3.89 million iso4217-usd
2017 Q4 · iso4217-usd
Exact inputs and evidence
- Revenue: 3890000 iso4217-usd Source
Fundies. English
BIOCRYST PHARMACEUTICALS INC
EDGAR312 filing records in this dataset, filed from 1996-08-13 to 2026-08-05. Reported financial figures are available; chart coverage varies by period.
Latest quarter
Operating margin
-459.15%
2017 Q4 · %
Operating cash flow
-10.5 million iso4217-usd
2017 Q4 · iso4217-usd
- Cash and cash equivalents
- 155 million USD Source
Exact value
154972000 USD
- Long-term debt including current maturities
- 298 million USD Source
Exact value
298142000 USD
- Shares outstanding
- 255 million shares Source
Exact value
255265000 shares
Reported share-count change
21.61% · 45.4 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
25.2 million iso4217-usd
2017-01-01 – 2017-12-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-05.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 3 of 11 periods available· newest 2017-12-31
- Operating income: 8 of 11 periods available· newest 2025-12-31
- Net income: 8 of 11 periods available· newest 2025-12-31
- Operating cash flow: 8 of 11 periods available· newest 2025-12-31
- Capital expenditure: 3 of 11 periods available· newest 2019-12-31
- Total assets: 7 of 11 periods available· newest 2025-12-31
- Total liabilities: 3 of 11 periods available· newest 2025-12-31
- Current assets: 7 of 11 periods available· newest 2025-12-31
- Current liabilities: 7 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 7 of 11 periods available· newest 2025-12-31
- Long-term debt including current maturities: 2 of 11 periods available· newest 2021-12-31
- Shares outstanding: 7 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+USD 352.74 millionPrior period
−USD 88.88 million
–
Current period
USD 263.86 million
–
Exact inputs and evidence
263861000 − -88881000 = 352742000 USD
-88881000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source263861000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 399.39 millionPrior period
−USD 52.02 million
–
Current period
USD 347.37 million
–
Exact inputs and evidence
347369000 − -52020000 = 399389000 USD
-52020000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source347369000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2017 2017-01-01 – 2017-12-31
- Revenue iso4217-usd 25.19 million 100% of revenue
- Operating costs Derived Unavailable An input is unavailable.
- Operating income Unavailable An input is unavailable.
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income Unavailable An input is unavailable.
Cash
- Operating cash flow Unavailable An input is unavailable.
- Capital expenditure iso4217-usd 328,000 1.3% of revenue
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2015 Not shown: operating income or net income is not reported.
- 2016 Not shown: operating income or net income is not reported.
- 2017 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | 48257000 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
| 2016 2016-01-01 – 2016-12-31 | 26353000 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
| 2017 2017-01-01 – 2017-12-31 | 25186000 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
Amounts are exact, in iso4217-usd.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
iso4217-usd 25.2M 2017
Values and sources
| Period | Series | Value(iso4217-usd) | Source evidence |
|---|---|---|---|
| 2015 | Revenue | 48257000 |
|
| 2016 | Revenue | 26353000 |
|
| 2017 | Revenue | 25186000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
-4.4% 2017
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015 | Year over year | No prior comparable period |
|
| 2016 | Year over year | -45.4% |
|
| 2017 | Year over year | -4.4% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-12-31 | Operating margin | Not reported |
|
| 2016-12-31 | Operating margin | Not reported |
|
| 2017-12-31 | Operating margin | Not reported |
|
| 2015-12-31 | Net margin | Not reported |
|
| 2016-12-31 | Net margin | Not reported |
|
| 2017-12-31 | Net margin | Not reported |
|
| 2015 | Free cash flow margin | Not reported |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(iso4217-usd) | Source evidence |
|---|---|---|---|
| 2015 | Operating cash flow | Not reported | No source recorded |
| 2016 | Operating cash flow | Not reported | No source recorded |
| 2017 | Operating cash flow | Not reported | No source recorded |
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(iso4217-usd) | Source evidence |
|---|---|---|---|
| 2015 | Free cash flow | Unavailable | No source recorded |
| 2016 | Free cash flow | Unavailable | No source recorded |
| 2017 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2016-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2017-12-31 | Liabilities / assets | Not reported | No source recorded |
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2015-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2016-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2017-12-31 | Current assets / current liabilities | Not reported | No source recorded |
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | −USD 101.25 million Exact valueExact value: -101252000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 92.57 million Exact valueExact value: -92565000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 108.9 million Exact valueExact value: -108897000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 89.58 million Exact valueExact value: -89584000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 182.81 million Exact valueExact value: -182814000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 135.11 million Exact valueExact value: -135108000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 184.06 million Exact valueExact value: -184062000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 142.16 million Exact valueExact value: -142157000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 247.12 million Exact valueExact value: -247116000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 161.85 million Exact valueExact value: -161850000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 226.54 million Exact valueExact value: -226539000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 95.14 million Exact valueExact value: -95141000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 88.88 million Exact valueExact value: -88881000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 52.02 million Exact valueExact value: -52020000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | USD 263.86 million Exact valueExact value: 263861000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 347.37 million Exact valueExact value: 347369000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
312 filings · 4,094 latest values · 4,094 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000882796, 882796, BCRX, bcrx, edgar:882796
Also known as BIOCRYST PHARMACEUTICALS INC, BIOCRYST PHARMACEUTICALS, INC., BioCryst Pharmaceuticals, Inc.